Spectral-Domain OCT Analyses of Macular Changes After Ranibizumab Therapy for Type 1 Retinopathy of Prematurity

EROL, Muhammet; COBAN, Deniz; OZDEMIR, Ozdemir; TUNAY, Zuhal; BİLGİN, AHMET; DOGAN, Berna

doi:10.3928/01913913-20150326-12

Spectral-Domain OCT Analyses of Macular Changes After Ranibizumab Therapy for Type 1 Retinopathy of Prematurity

Copy For Citation

EROL M. K., COBAN D. T., OZDEMIR O., TUNAY Z. O., BİLGİN A. B., DOGAN B.

JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS, vol.52, no.3, pp.152-158, 2015 (SCI-Expanded)

Publication Type: Article / Article
Volume: 52 Issue: 3
Publication Date: 2015
Doi Number: 10.3928/01913913-20150326-12
Journal Name: JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.152-158
Akdeniz University Affiliated: Yes

Abstract

Purpose: To investigate the clinical and macular spectral-domain optical coherence tomography (SD-OCT) findings after intravitreal ranibizumab treatment for type 1 retinopathy of prematurity (ROP).